06/26/2025
3:08 PM | Protagonist Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2025
4:30 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Protagonist Therapeutics (Subject)
| Form SCHEDULE 13G | |
06/11/2025
4:40 PM | MOLINA ARTURO MD (Reporting)
Protagonist Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2025
4:51 PM | MOLINA ARTURO MD (Reporting)
Protagonist Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/09/2025
3:46 PM | MOLINA ARTURO MD (Reporting)
Protagonist Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/13/2025
11:10 AM | Protagonist Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SCHEDULE 13G | |
05/06/2025
3:27 PM | Protagonist Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2025
3:10 PM | Protagonist Therapeutics (Filer)
| Form ARS | |
04/29/2025
1:53 PM | BlackRock, Inc. (Filed by)
Protagonist Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
04/23/2025
3:30 PM | Ali Asif (Reporting)
Protagonist Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2025
3:14 PM | Deep Track Capital, LP (Filed by)
Protagonist Therapeutics (Subject)
| Form SCHEDULE 13G | |
Get the Latest News and Ratings for PTGX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Protagonist Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
03/17/2025
3:30 PM | Protagonist Therapeutics (Subject)
Waddill William D. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/14/2025
5:20 PM | Ali Asif (Reporting)
Protagonist Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2025
5:21 PM | MOLINA ARTURO MD (Reporting)
Protagonist Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2025
4:24 PM | MOLINA ARTURO MD (Reporting)
Protagonist Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/12/2025
4:31 PM | Ali Asif (Reporting)
Protagonist Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/10/2025
7:17 AM | Protagonist Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2025
7:02 PM | PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
7:18 AM | Protagonist Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2025
3:36 PM | Protagonist Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/21/2025
6:07 AM | Protagonist Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2025
4:25 PM | PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
8:00 AM | Farallon Capital Partners, L.P. (Filed by)
Protagonist Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/05/2025
12:23 PM | BlackRock, Inc. (Filed by)
Protagonist Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/17/2025
4:45 PM | Ali Asif (Reporting)
Protagonist Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2025
4:46 PM | PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2025
4:47 PM | MOLINA ARTURO MD (Reporting)
Protagonist Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
5:07 PM | Giraudo Bryan (Reporting)
Protagonist Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
5:07 PM | PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
5:08 PM | Protagonist Therapeutics (Issuer)
SELICK HAROLD E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
5:09 PM | Protagonist Therapeutics (Issuer)
Williams Lewis T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
5:10 PM | O'Dowd Sarah A (Reporting)
Protagonist Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
5:11 PM | Protagonist Therapeutics (Issuer)
Waddill William D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
5:05 PM | Ali Asif (Reporting)
Protagonist Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
5:06 PM | MOLINA ARTURO MD (Reporting)
Protagonist Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
6:09 PM | Gupta Suneel (Reporting)
Protagonist Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
6:11 PM | MOLINA ARTURO MD (Reporting)
Protagonist Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
6:08 PM | PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2024
6:37 PM | Gupta Suneel (Reporting)
Protagonist Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/26/2024
6:39 PM | MOLINA ARTURO MD (Reporting)
Protagonist Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/25/2024
4:40 PM | Gupta Suneel (Reporting)
Protagonist Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Presidential Bombshell: $150T Resource to Be Released as soon as this Summer? (Ad) Something extraordinary is happening in Washington.
For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations.
I'm talking about a $150 trillion American asset that's scattered across all 50 states.
While the mainstream media focuses on political theater, this story is quietly developing behind closed doors. We recently interviewed Rickards to get the full story and understand how everyday Americans can pre |
11/21/2024
3:01 PM | PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
5:49 PM | MOLINA ARTURO MD (Reporting)
Protagonist Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2024
3:36 PM | Protagonist Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:27 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Protagonist Therapeutics (Subject)
| Form SC 13G/A | |
11/12/2024
3:51 PM | Protagonist Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/07/2024
3:39 PM | Protagonist Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/04/2024
12:22 PM | Protagonist Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/16/2024
11:48 AM | Protagonist Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G | |
09/13/2024
3:35 PM | Ali Asif (Reporting)
Protagonist Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
6:38 PM | Protagonist Therapeutics (Issuer)
Waddill William D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
5:15 PM | Ali Asif (Reporting)
Protagonist Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024
3:17 PM | Protagonist Therapeutics (Subject)
Waddill William D. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/06/2024
3:18 PM | Protagonist Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/06/2024
6:08 AM | Protagonist Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/26/2024
3:31 PM | Protagonist Therapeutics (Issuer)
Waddill William D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2024
3:33 PM | Protagonist Therapeutics (Subject)
Waddill William D. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Free PTGX Stock Alerts